✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Vista Pharmaceuticals Ltd.

VISTAPH

Market Cap
₹61 Cr.
P/E
0.00

Vista Pharmaceuticals Ltd.

  • Vista Pharma
  • Shanmuga Hospital
  • Medicamen Organics
FAQs on Vista Pharmaceuticals Ltd. Shareprice

Vista Pharma has given lower returns compared to its competitors.
Vista Pharma has grown at ~-18.0% over the last 1yrs while peers have grown at a median rate of -7.36%

There is insufficient historical data to gauge this.
Latest PE of Vista Pharma is 0

View FAQ's On Business
Growth Table
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Balance Sheet
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Cash Flow
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Quarterly Results
  • Vista Pharmaceuticals Ltd.
  • Shanmuga Hospital
  • Medicamen Organics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vista Pharmaceuticals Ltd. Financials

Balance sheet of Vista Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Vista Pharma is decreasing.
Latest net debt of Vista Pharma is ₹6.67 Crs as of Mar-25.
This is less than Mar-24 when it was ₹7.8 Crs.

The profit is oscillating.
The profit of Vista Pharma is -₹4.65 Crs for TTM, -₹4.51 Crs for Mar 2024 and -₹5.66 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vista Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech